Algert Global’s Natus Medical Inc NTUS Stock Holding History

Algert Global’s Portfolio NTUS Stock Details NTUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-8,709	Closed	-$285K	–	1408
2022 Q2	$285K	Sell	8,709 -31,802	-79%	-$1.01M	0.02%	935
2022 Q1	$1.06M	Buy	40,511 +12,609	+45%	+$308K	0.07%	493
2021 Q4	$662K	Sell	27,902 -4,180	-13%	-$103K	0.08%	433
2021 Q3	$805K	Buy	32,082 +19,952	+164%	+$508K	0.11%	335
2021 Q2	$315K	Buy	+12,130	New	+$330K	0.11%	278
2018 Q4	–	Sell	-18,024	Closed	-$643K	–	429
2018 Q3	$643K	Buy	+18,024	New	+$636K	0.14%	221
2017 Q2	–	Sell	-12,216	Closed	-$479K	–	372
2017 Q1	$479K	Buy	+12,216	New	+$458K	0.13%	236

Other funds holding NTUS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Algert Global's NTUS Position: Q3 2022 in Review

Algert Global sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 8,709 shares — an estimated $285K sold.

Algert Global first reported a position in NTUS in Q1 2017 and held it in 7 quarters. The position peaked at $1.06M in Q1 2022. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.

Algert Global reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
Algert Global sold 8,709 Natus Medical Inc shares in Q3 2022, an estimated $285K.
Algert Global first reported a position in Natus Medical Inc in Q1 2017 and held it in 7 quarters.
Algert Global's Natus Medical Inc position peaked at $1.06M in Q1 2022.
1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.

Based on Algert Global's 13F filing for Q3 2022, filed 15 Nov 2022.